Meitav Dash Investments LTD Biogen Inc. Transaction History

Meitav Dash Investments LTD

$5.8 Billion
Q3 2024

A detailed history of Meitav Dash Investments LTD transactions in Biogen Inc. stock. As of the latest transaction made, Meitav Dash Investments LTD holds 16,852 shares of BIIB stock, worth $2.93 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

16,852

Previous 16,852 -0.0%

Holding current value

$2.93 Million

Previous $3.91 Million 16.39%

% of portfolio

0.06%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$190.52 - $236.72 $2,286 - $2,840	12 Added 0.07%	16,852 $3.91 Million
Q1 2024 May 01, 2024	BUY	$212.02 - $267.71 $8,480 - $10,708	40 Added 0.24%	16,840 $3.63 Million
Q4 2023 Jan 29, 2024	BUY	$222.59 - $267.94 $1,780 - $2,143	8 Added 0.05%	16,800 $4.35 Million
Q3 2023 Oct 30, 2023	BUY	$253.3 - $285.89 $675,551 - $762,468	2,667 Added 18.88%	16,792 $4.32 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $1.44 Million - $1.64 Million	5,600 Added 65.69%	14,125 $3.93 Million
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $1.65 Million - $2.27 Million	-8,468 Reduced 49.83%	8,525 $2.25 Million
Q2 2022 Aug 01, 2022	BUY	$187.54 - $223.02 $221,484 - $263,386	1,181 Added 7.47%	16,993 $3.47 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $3.06 Million - $3.86 Million	15,812 New	15,812 $3.33 Million
Q3 2021 Nov 03, 2021	SELL	$282.99 - $369.05 $230,636 - $300,775	-815 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $207,200 - $331,768	-800 Reduced 49.54%	815 $282,000
Q1 2021 May 06, 2021	SELL	$242.95 - $284.63 $62,924 - $73,719	-259 Reduced 13.82%	1,615 $449,000
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $23,626 - $35,563	-100 Reduced 5.07%	1,874 $457,000
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $52,954 - $61,141	-200 Reduced 9.2%	1,974 $558,000
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $355,398 - $470,663	1,374 Added 171.75%	2,174 $572,000
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $53,770 - $68,208	-200 Reduced 20.0%	800 $253,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $220,060 - $304,070	1,000 New	1,000 $297,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $6.77 Million - $10.6 Million	-31,220 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $12,811 - $16,226	-46 Reduced 0.15%	31,220 $9.4 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $1.96 Million - $2.57 Million	-6,684 Reduced 17.61%	31,266 $11.1 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $69,530 - $82,865	-270 Reduced 0.71%	37,950 $11 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $72,836 - $103,014	280 Added 0.74%	38,220 $10.5 Million
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $11.7 Million - $13.1 Million	37,940	37,940 $12.1 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Account

Meitav Dash Investments LTD Biogen Inc. Transaction History